These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5420141)

  • 41. Subcellular localization of H3-norepinephrine in the rat brain and the effect of drugs.
    Glowinski J; Snyder SH; Axelrod J
    J Pharmacol Exp Ther; 1966 May; 152(2):282-92. PubMed ID: 5944370
    [No Abstract]   [Full Text] [Related]  

  • 42. Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.
    Su C; Bevan JA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):533-40. PubMed ID: 5481718
    [No Abstract]   [Full Text] [Related]  

  • 43. Regeneration of sympathetic nerves to the vas deferens and spleen of the cat.
    Kirpekar SM; Wakade AR; Prat JC
    J Pharmacol Exp Ther; 1970 Oct; 175(1):197-205. PubMed ID: 5528539
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.
    Obianwu HO
    Br J Pharmacol; 1968 Sep; 34(1):226P-227P. PubMed ID: 5676028
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antidromic activity induced by acetylcholine in the cardiac sympathetic nerve, and noradrenaline liberation under the influence of guanethidine].
    Häusler G; Thoenen H; Haefely W; Hürlimann A
    Helv Physiol Pharmacol Acta; 1968; 26(3):CR352-4. PubMed ID: 5719362
    [No Abstract]   [Full Text] [Related]  

  • 46. The chemorelease of norepinephrine from mouse hearts by substituted amphetamines.
    Benington F; Morin RD
    J Med Chem; 1968 Jul; 11(4):896-7. PubMed ID: 5677681
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanism of the inhibitory action of guanethidine on cardiovascular responses to tyramine and amphetamine.
    BHAGAT B; SHIKEMAN FE
    J Pharmacol Exp Ther; 1963 Jun; 140():317-23. PubMed ID: 13967970
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of d-amphetamine on the electroencephalogram of the dog.
    SCHALLEK W; WALZ D
    Proc Soc Exp Biol Med; 1953 Apr; 82(4):715-9. PubMed ID: 13055981
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of d-amphetamine sulfate on the level of the circulating eosinophils.
    BAUER CW; GLICKMAN ME
    J Am Pharm Assoc Am Pharm Assoc; 1952 Nov; 41(11):576-8. PubMed ID: 12999620
    [No Abstract]   [Full Text] [Related]  

  • 51. Physiological costs incurred by dextroamphetamine.
    HAUTY GT; PAYNE RB; BAUER RO
    J Comp Physiol Psychol; 1957 Dec; 50(6):647-51. PubMed ID: 13502516
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of amphetamines upon judgments and decisions.
    Hurst PM; Weidner MF; Radlow R
    Psychopharmacologia; 1967 Oct; 11(5):397-404. PubMed ID: 5587643
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of normal air and dextro-amphetamine upon work decrement induced by oxygen impoverishment and fatigue.
    HAUTY GT; PAYNE RB; BAUER RO
    J Pharmacol Exp Ther; 1957 Mar; 119(3):385-9. PubMed ID: 13417093
    [No Abstract]   [Full Text] [Related]  

  • 54. Olfactory acuity in normal and obese human subjects: diurnal variations and the effect of d-amphetamine sulphate.
    GUILD AA
    J Laryngol Otol; 1956 Jul; 70(7):408-14. PubMed ID: 13346212
    [No Abstract]   [Full Text] [Related]  

  • 55. Chlorpromazine reversal of the antihypertensive action of guanethidine.
    Fann WE; Janowsky DS; Davis JM; Oates JA
    Lancet; 1971 Aug; 2(7721):436-7. PubMed ID: 4105208
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the excretion of guanethidine (Ismelin) metabolites in the urine of hypertonics].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1969; 75():157-9. PubMed ID: 5400111
    [No Abstract]   [Full Text] [Related]  

  • 57. Transmission to the longitudinal muscle of the guinea-pig vas deferens: The effect of pretreatment with guanethidine.
    Furness JB
    Br J Pharmacol; 1974 Jan; 50(1):63-8. PubMed ID: 4150890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.
    Lam YW; Shepherd AM
    Clin Pharmacokinet; 1990 Apr; 18(4):295-317. PubMed ID: 2182265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug interactions with guanidinium antihypertensives.
    Stafford JR; Fann WE
    Drugs; 1977 Jan; 13(1):57-64. PubMed ID: 64339
    [No Abstract]   [Full Text] [Related]  

  • 60. The mechanism of the reversal of the effect of guanethidine by amphetamines in cat and man.
    Flegin OT; Morgan DH; Oates JA; Shand DG
    Br J Pharmacol; 1970 May; 39(1):253P-254P. PubMed ID: 5420141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.